Exelixis at Stifel 2026 Healthcare Conference: zanzalintinib push

🌐 Investing.com (Cyprus) — 2026-11-11

Exelixis discussed its push to advance zanzalintinib at the Stifel 2026 Healthcare Conference. The headline does not provide additional clinical, regulatory, or commercial details.

Markets Health Exelixis zanzalintinib healthcare conference drug development biopharmaceuticals

Read original source →

Burnham Heads to COP31 Torn Between Cheaper Power and Net Zero
Oilprice.com — 2026-11-11
Magna International Inc. (MG:CA) Analyst/Investor Day Transcript
Seeking Alpha — 2026-11-11
Capital One Financial Corporation (COF) Presents at KBW Fintech Ecosystem Conference 2026 Transcript
Seeking Alpha — 2026-11-11
American Express Company (AXP) Presents at KBW Fintech Ecosystem Conference 2026 Transcript
Seeking Alpha — 2026-11-11
Evolution Petroleum Corporation (EPM) Q1 2027 Earnings Call Transcript
Seeking Alpha — 2026-11-11
Micron: Strong Buy Even Under Severe Cyclical Pessimism
Seeking Alpha — 2026-11-11

Exelixis at Stifel 2026 Healthcare Conference: zanzalintinib push

AI Summary

Related Articles

Burnham Heads to COP31 Torn Between Cheaper Power and Net Zero

Magna International Inc. (MG:CA) Analyst/Investor Day Transcript

Capital One Financial Corporation (COF) Presents at KBW Fintech Ecosystem Conference 2026 Transcript

American Express Company (AXP) Presents at KBW Fintech Ecosystem Conference 2026 Transcript

Evolution Petroleum Corporation (EPM) Q1 2027 Earnings Call Transcript

Micron: Strong Buy Even Under Severe Cyclical Pessimism